Iradimed (IRMD) Intangibles (2013 - 2026)

Iradimed (IRMD) has 14 years of Intangibles data on file, last reported at $3.3 million in Q1 2026.

• Intangibles for Q1 2026 came in at $3.3 million, down 27.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.3 million (down 27.02% YoY), and the FY2025 annual result was $3.4 million, down 20.99% from the prior year.
• Intangibles eased to $3.3 million in Q1 2026 per IRMD's latest filing, from $3.4 million in the prior quarter.
• Over five years, Intangibles peaked at $4.8 million in Q3 2025 and troughed at $1.3 million in Q1 2022.
• A 5-year average of $3.1 million and a median of $3.3 million in 2026 frame the typical range for Intangibles.
• The sharpest annual moves came in 2023 and 2026: Intangibles soared 129.68% in 2023, then fell 27.02% in 2026.
• A 5-year view of Intangibles shows it stood at $2.1 million in 2022, then soared by 67.73% to $3.5 million in 2023, then increased by 23.39% to $4.3 million in 2024, then declined by 20.99% to $3.4 million in 2025, then slipped by 2.9% to $3.3 million in 2026.
• Business Quant data shows IRMD's Intangibles at $3.3 million in Q1 2026, $3.4 million in Q4 2025, and $4.8 million in Q3 2025.